Home » Pharmaceutical » Drug Discovery Services Market Size, Share, Analysis Report
The major factors driving the expansion of this market are increasing analysis and development expenditure, inclination of major pharmaceutical companies towards outsourcing to avoid hurdles and increasing demand for outsourcing of analytical testing and clinical test services. However, the high value concerned in drug discovery and development, demanding regulations governing drug discovery, and animal usage are restraining the expansion of this market.
How Big is The Global Drug Discovery Services Market?
The Drug Discovery Services Market is expected to be around US$ 21.80 Billion by 2028 at a CAGR of 11% in the given forecast period.
The major driving factors of Drug Discovery Services Market are as follows:
The major restraints factors of Drug Discovery Services Market are as follows:
The Drug Discovery Services Market has been segmented as below:
By Type:
By Drug Type:
By Therapeutic Area:
By Regional Analysis:
The Drug Discovery Services Market is segmented on the lines of its type, drug type, therapeutic area and regional. Based on type it covers Medicinal Chemistry, Biology Services and Drug Metabolism and Pharmacokinetics (DMPK). Based on drug type it covers Small Molecules and Biologics. Based on therapeutic area it covers Oncology, Neurology, Cardiovascular Diseases, Respiratory Diseases, Diabetes and Other Therapeutic Areas. The Drug Discovery Services Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for Drug Discovery Services Market and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for Drug Discovery Services Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
Report Scope:
The scope of the report includes a detailed study of Drug Discovery Services Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report Thermo Fisher Scientific, Merck, Healthcare, Albany Molecular Research, Inc, Charles River Laboratories International, Evotec, Pharmaceutical Product Development, LLC, Jubilant Biosys, Covance, Genscript Biotech Corporation, Aurigene Discovery Technologies and Wuxi Apptec. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Drug Discovery Services Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Drug Discovery Services Market.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our New Reports :-
Erythropoietin (EPO) Drugs Market
1. Introduction
1.1 Key Findings
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Data
2.2 Market Size Estimation and Data Triangulation
2.3 Research Assumptions
3. Summary with Insights
4. Market Overview
4.1 Introduction
4.2 Drivers
4.3 Restraints
4.4 Industry Trends
4.5 Porter’s Five Forces Analysis
5. Drug Discovery Services Market Analysis, By Type
5.1 Medicinal Chemistry
5.2 Biology Services
5.3 Drug Metabolism and Pharmacokinetics (DMPK)
6. Drug Discovery Services Market Analysis, By Drug Type
6.1 Small Molecules
6.2 Biologics
7. Drug Discovery Services Market Analysis, By Therapeutic Area
7.1 Oncology
7.2 Neurology
7.3 Cardiovascular Diseases
7.4 Respiratory Diseases
7.5 Diabetes
7.6 Other Therapeutic Areas
8. Drug Discovery Services Market Analysis, By Region
8.1 North America
8.2 Europe
8.3 Asia-Pacific
8.4 Rest of the World
9. Competitive Overview
9.1 Introduction
9.2 New Product Launches
9.3 Acquisitions
9.4 Agreements, Partnerships, And Collaborations
9.5 Expansions
10. Company Profiles
10.1 Merck
10.2 Healthcare
10.3 Evotec
10.4 Thermo Fisher Scientific
10.5 Aurigene Discovery Technologies
10.6 Charles River Laboratories International
10.7 Wuxi Apptec
10.8 Pharmaceutical Product Development, LLC.
10.9 Jubilant Biosys
10.10 Albany Molecular Research, Inc.
10.11 Covance
10.12 Genscript Biotech Corporation
The Drug Discovery Services Market has been segmented as below:
By Type:
By Drug Type:
By Therapeutic Area:
By Regional Analysis:
SUBSCRIBE TO OUR NEWSLETTERS